+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theranostics Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Theranostics Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Theranostics Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083045
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The theranostics market is rapidly transforming clinical care pathways, driven by the fusion of advanced diagnostic imaging and targeted therapies. Senior leaders evaluating strategic expansion or innovation must recognize how evolving technologies, regulatory frameworks, and global dynamics are reshaping decision-making and investment priorities.

Market Snapshot: Theranostics Market Size and Growth

The Theranostics Market grew from USD 2.67 billion in 2024 to USD 3.09 billion in 2025. It is expected to continue growing at a CAGR of 15.03%, reaching USD 6.19 billion by 2030.

Scope & Segmentation of the Theranostics Market

  • Product Types: Imaging agents such as hybrid tracers, PET and SPECT agents; radiopharmaceuticals including both diagnostic and therapeutic applications; and an array of advanced therapeutic agents.
  • Technologies: Hybrid imaging systems, PET/CT and PET/MRI technologies, SPECT/CT platforms, and rapid synthesis units that support decentralized production.
  • Applications: Cardiology applications focus on diagnostics and imaging for heart failure and myocardial perfusion; neurology targets neurodegenerative conditions; oncology leverages tracers and therapies for cancers such as breast, lung, and prostate.
  • End Users: Stakeholders served include clinics, diagnostic centers, hospitals, and research laboratories, each requiring tailored product and service delivery.
  • Regions: Coverage spans the Americas (with focus on the United States, Canada, Brazil, and key states), Europe, Middle East & Africa (including EU nations, Gulf countries, and emerging African markets), and Asia-Pacific (notably China, India, Japan, Australia, South Korea, and others).
  • Key Companies: Notable players analyzed include Novartis AG, Lantheus Holdings, Bayer AG, GE HealthCare Technologies, Telix Pharmaceuticals, Bracco Imaging, Curium Pharma, Cardinal Health, Jubilant Pharmova, and Ion Beam Applications.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Technological convergence is transforming how imaging and therapy are integrated, with real-time biomarker feedback supporting adaptive treatment protocols.
  • Hybrid imaging adoption is accelerating, particularly PET/MRI and PET/CT, meeting clinician demand for higher molecular specificity in oncology and neurology.
  • Regulatory trends now favor expedited pathways for radiopharmaceuticals combined with diagnostic agents, supporting faster market entry and encouraging clinical trial partnerships.
  • Expansion of modular radiopharmacy and decentralized tracer synthesis facilities is enhancing production flexibility, improving global access, and bolstering supply chain resilience.
  • Emerging markets, especially in Asia-Pacific, exhibit the fastest adoption rates, with rising demand being addressed through local manufacturing and public-private partnerships.
  • Strategic collaborations among equipment vendors, biotech firms, and software developers are central for product differentiation and delivery of integrated solutions.

Evaluating Tariff Impact on Theranostics Trade

The 2025 United States tariffs on imported diagnostic equipment and radiopharmaceutical precursors have introduced added complexity and costs within supply chains. Manufacturers and suppliers are pursuing domestic investments in cyclotron installs and automated facilities to offset duty impacts and ensure consistent access to high-purity materials. Regional alliances and bundled service models are emerging in response, enabling organizations to strengthen their logistics and adapt to shifting procurement environments.

Methodology & Data Sources

This analysis employs robust secondary research—leveraging regulatory filings, industry journals, white papers, and corporate disclosures—combined with primary interviews across C-suite executives, clinicians, procurement teams, and regulatory authorities. Triangulation methods ensure both consistency and accuracy of quantitative and qualitative insights.

Why This Report Matters: Actionable Outcomes for Leaders

  • Enables precise market identification and risk mitigation through in-depth segmentation and competitor benchmarking, resulting in more targeted investment.
  • Assesses the real-world impact of policy shifts and supply chain disruptions so leaders can proactively adjust operational or sourcing strategies.
  • Provides clear guidance on portfolio and geographic expansion by illuminating local market dynamics and regulatory considerations.

Conclusion

The theranostics market is steering a paradigm shift in precision healthcare, supported by continual innovation and expanding regional adoption. Senior decision-makers leveraging these strategic insights will be positioned for enduring leadership and measurable value creation in this evolving sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Theranostics Market, by Product Type
8.1. Introduction
8.2. Imaging Agents
8.2.1. Hybrid Imaging Agents
8.2.2. Positron Emission Tomography Agents
8.2.3. Single Photon Emission Computed Tomography Agents
8.3. Radiopharmaceuticals
8.3.1. Diagnostic Radiopharmaceuticals
8.3.1.1. Fluorodeoxyglucose
8.3.1.2. Gallium Generators
8.3.2. Therapeutic Radiopharmaceuticals
8.3.2.1. Alpha Emitters
8.3.2.2. Radionuclide Therapy Agents
8.4. Therapeutic Agents
8.4.1. Peptide Receptor Radionuclide Therapy
8.4.2. Targeted Alpha Therapy
9. Theranostics Market, by Technology
9.1. Introduction
9.2. Hybrid Imaging Systems
9.3. Positron Emission Tomography
9.3.1. PET/CT Systems
9.3.2. PET/MRI Systems
9.4. Single Photon Emission Computed Tomography
9.4.1. SPECT/CT Systems
10. Theranostics Market, by Application
10.1. Introduction
10.2. Cardiology
10.2.1. Heart Failure Diagnosis
10.2.2. Myocardial Perfusion Imaging
10.3. Neurology
10.3.1. Alzheimer Disease
10.3.2. Parkinson Disease
10.4. Oncology
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Prostate Cancer
11. Theranostics Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Research Laboratories
12. Americas Theranostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Theranostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Theranostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novartis AG
15.3.2. Lantheus Holdings, Inc.
15.3.3. Bayer AG
15.3.4. GE HealthCare Technologies Inc.
15.3.5. Telix Pharmaceuticals Limited
15.3.6. Bracco Imaging S.p.A.
15.3.7. Curium Pharma
15.3.8. Cardinal Health, Inc.
15.3.9. Jubilant Pharmova Limited
15.3.10. Ion Beam Applications S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. THERANOSTICS MARKET MULTI-CURRENCY
FIGURE 2. THERANOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. THERANOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERANOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THERANOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY HYBRID IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORODEOXYGLUCOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM GENERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY RADIONUCLIDE THERAPY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY PEPTIDE RECEPTOR RADIONUCLIDE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY HYBRID IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY PET/MRI SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY HEART FAILURE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 87. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 88. CANADA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 89. CANADA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 90. CANADA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. CANADA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 92. CANADA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 93. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CANADA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 96. CANADA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 97. CANADA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. GERMANY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. GERMANY THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 171. GERMANY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 173. GERMANY THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 174. GERMANY THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. GERMANY THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 178. GERMANY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 180. GERMANY THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 181. GERMANY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. FRANCE THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 187. FRANCE THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 189. FRANCE THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. FRANCE THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 191. FRANCE THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 192. FRANCE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. FRANCE THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 194. FRANCE THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 196. FRANCE THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. ITALY THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 213. ITALY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 214. ITALY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 215. ITALY THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 216. ITALY THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 217. ITALY THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. ITALY THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 219. ITALY THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 220. ITALY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. ITALY THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 222. ITALY THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 224. ITALY THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SPAIN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SPAIN THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 227. SPAIN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 228. SPAIN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 229. SPAIN THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 230. SPAIN THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 231. SPAIN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SPAIN THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 233. SPAIN THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 234. SPAIN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SPAIN THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SPAIN THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 237. SPAIN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SPAIN THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. DENMARK THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. DENMARK THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 283. DENMARK THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 284. DENMARK THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 285. DENMARK THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 286. DENMARK THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 287. DENMARK THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. DENMARK THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 289. DENMARK THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 290. DENMARK THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. DENMARK THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 292. DENMARK THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 293. DENMARK THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 294. DENMARK THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. QATAR THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. QATAR THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 311. QATAR THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. QATAR THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 313. QATAR THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 314. QATAR THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 315. QATAR THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. QATAR THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 317. QATAR THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 318. QATAR THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. QATAR THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 320. QATAR THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 321. QATAR THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 322. QATAR THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. FINLAND THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. FINLAND THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 325. FINLAND THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 326. FINLAND THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 327. FINLAND THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 328. FINLAND THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 329. FINLAND THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. FINLAND THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 331. FINLAND THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 332. FINLAND THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. FINLAND THERANOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 334. FINLAND THERANOSTICS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 335. FINLAND THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 336. FINLAND THERANOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN THERANOSTICS MARKET SIZE, BY IMAGING AGENTS, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN THERANOSTICS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, 2018-2030 (USD MILLION)
TABLE 343. SWEDEN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. SWEDEN THERANOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 345. SWEDEN THERANOSTICS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 346. SWEDEN THERANOSTICS MARKET SIZE, BY AP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Theranostics market report include:
  • Novartis AG
  • Lantheus Holdings, Inc.
  • Bayer AG
  • GE HealthCare Technologies Inc.
  • Telix Pharmaceuticals Limited
  • Bracco Imaging S.p.A.
  • Curium Pharma
  • Cardinal Health, Inc.
  • Jubilant Pharmova Limited
  • Ion Beam Applications S.A.

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.19 Billion
Compound Annual Growth Rate15.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Radiopharmaceutical Theranostics Market Report 2025 - Product Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical Theranostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Radiopharmaceutical Theranostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 105 Pages
  • Global
From
Theranostics Market Report 2025 - Product Image

Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Theranostics: Global Markets 2024-2029 - Product Image

Theranostics: Global Markets 2024-2029

  • Report
  • 118 Pages
  • Global
From

About the Theranostics Market

Theranostics is a field of medicine that combines diagnostics and therapeutics to provide personalized treatments for patients. It is closely related to genomics, which is the study of an individual's genetic makeup. Theranostics uses genomic information to identify the best treatment for a patient, based on their unique genetic profile. This approach is becoming increasingly popular as it allows for more precise and effective treatments. Theranostics is used in a variety of medical fields, including oncology, neurology, and cardiology. It is also being used to develop new treatments for rare diseases. By combining genomic data with other medical information, such as imaging and laboratory tests, doctors can better understand a patient's condition and develop more effective treatments. Some companies in the Theranostics market include Illumina, Thermo Fisher Scientific, and Qiagen. These companies provide products and services related to genomics, such as DNA sequencing, gene expression analysis, and bioinformatics. They also offer products and services related to theranostics, such as biomarker discovery and drug development. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.